119 related articles for article (PubMed ID: 9249205)
1. Comparison of the in-vitro and in-vivo efficacy of FK037, vancomycin, imipenem and nafcillin against staphylococcal species.
Climo MW; Markowitz SM; Williams DS; Hale-Cooper CG; Archer GL
J Antimicrob Chemother; 1997 Jul; 40(1):59-66. PubMed ID: 9249205
[TBL] [Abstract][Full Text] [Related]
2. Excellent activity of FK037, a novel parenteral broad-spectrum cephalosporin, against methicillin-resistant staphylococci.
Mine Y; Watanabe Y; Sakamoto H; Hatano K; Kuno K; Kamimura T; Tawara S; Matsumoto Y; Matsumoto F; Kuwahara S
J Antibiot (Tokyo); 1993 Jan; 46(1):99-119. PubMed ID: 8436564
[TBL] [Abstract][Full Text] [Related]
3. Successful therapy of experimental endocarditis caused by vancomycin-resistant Staphylococcus aureus with a combination of vancomycin and beta-lactam antibiotics.
Fox PM; Lampen RJ; Stumpf KS; Archer GL; Climo MW
Antimicrob Agents Chemother; 2006 Sep; 50(9):2951-6. PubMed ID: 16940087
[TBL] [Abstract][Full Text] [Related]
4. Comparative activity of CGP 31608, nafcillin, cefamandole, imipenem, and vancomycin against methicillin-susceptible and methicillin-resistant staphylococci.
Sachdeva M; Hackbarth C; Stella FB; Chambers HF
Antimicrob Agents Chemother; 1987 Oct; 31(10):1549-52. PubMed ID: 3481245
[TBL] [Abstract][Full Text] [Related]
5. Endocarditis due to methicillin-resistant Staphylococcus aureus in rabbits: expression of resistance to beta-lactam antibiotics in vivo and in vitro.
Chambers HF; Hackbarth CJ; Drake TA; Rusnak MG; Sande MA
J Infect Dis; 1984 Jun; 149(6):894-903. PubMed ID: 6564133
[TBL] [Abstract][Full Text] [Related]
6. In vitro antibacterial activities of FK037: a new parenteral cephalosporin.
Inoue K; Inoue E; Mitsuhashi S
Chemotherapy; 1995; 41(4):257-66. PubMed ID: 7555206
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo antibacterial activities of FK037, a novel parenteral broad-spectrum cephalosporin.
Fu KP; Foleno BD; Lafredo SC; LoCoco JM; Isaacson DM
Antimicrob Agents Chemother; 1993 Feb; 37(2):301-7. PubMed ID: 8452361
[TBL] [Abstract][Full Text] [Related]
8. Binding affinity for penicillin-binding protein 2a correlates with in vivo activity of beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus.
Chambers HF; Sachdeva M; Kennedy S
J Infect Dis; 1990 Sep; 162(3):705-10. PubMed ID: 2387996
[TBL] [Abstract][Full Text] [Related]
9. Combinations of vancomycin and beta-lactams are synergistic against staphylococci with reduced susceptibilities to vancomycin.
Climo MW; Patron RL; Archer GL
Antimicrob Agents Chemother; 1999 Jul; 43(7):1747-53. PubMed ID: 10390234
[TBL] [Abstract][Full Text] [Related]
10. Imipenem therapy of experimental Staphylococcus epidermidis endocarditis.
Berry AJ; Johnston JL; Archer GL
Antimicrob Agents Chemother; 1986 May; 29(5):748-52. PubMed ID: 3460523
[TBL] [Abstract][Full Text] [Related]
11. Comparative activities of telavancin combined with nafcillin, imipenem, and gentamicin against Staphylococcus aureus.
Leonard SN; Supple ME; Gandhi RG; Patel MD
Antimicrob Agents Chemother; 2013 Jun; 57(6):2678-83. PubMed ID: 23545527
[TBL] [Abstract][Full Text] [Related]
12. Comparative efficacies of imipenem, oxacillin and vancomycin for therapy of chronic foreign body infection due to methicillin-susceptible and -resistant Staphylococcus aureus.
Schaad HJ; Chuard C; Vaudaux P; Rohner P; Waldvogel FA; Lew DP
J Antimicrob Chemother; 1994 Jun; 33(6):1191-200. PubMed ID: 7928812
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo antibacterial activities of FK037, a new parenteral cephalosporin.
Nishino T; Otsuki M; Hatano K; Nishihara Y
Chemotherapy; 1994; 40(3):167-82. PubMed ID: 8205935
[TBL] [Abstract][Full Text] [Related]
14. Comparative efficacies of imipenem-cilastatin and vancomycin in experimental aortic valve endocarditis due to methicillin resistant Staphylococcus aureus.
Chandrasekar PH; Levine DP; Price S; Rybak MJ
J Antimicrob Chemother; 1988 Apr; 21(4):461-9. PubMed ID: 3378959
[TBL] [Abstract][Full Text] [Related]
15. An evaluation of the bactericidal activity of ampicillin/sulbactam, piperacillin/tazobactam, imipenem or nafcillin alone and in combination with vancomycin against methicillin-resistant Staphylococcus aureus (MRSA) in time-kill curves with infected fibrin clots.
Palmer SM; Rybak MJ
J Antimicrob Chemother; 1997 Apr; 39(4):515-8. PubMed ID: 9145825
[TBL] [Abstract][Full Text] [Related]
16. Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureus.
Fernandez-Guerrero M; Rouse M; Henry N; Wilson W
Antimicrob Agents Chemother; 1988 May; 32(5):747-51. PubMed ID: 3164989
[TBL] [Abstract][Full Text] [Related]
17. In vivo antibacterial activity of FK037, a novel parenteral broad-spectrum cephalosporin.
Mine Y; Watanabe Y; Sakamoto H; Hatano K; Wakai Y; Kamimura T; Tawara S; Matsumoto S; Matsumoto F; Kuwahara S
J Antibiot (Tokyo); 1993 Jan; 46(1):88-98. PubMed ID: 8436563
[TBL] [Abstract][Full Text] [Related]
18. Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus.
Chambers HF; Sande MA
Antimicrob Agents Chemother; 1984 Jul; 26(1):61-4. PubMed ID: 6236747
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity effects of combinations of cephalothin, dicloxacillin, imipenem, vancomycin and amikacin against methicillin-resistant Staphylococcus spp. strains.
Miranda-Novales G; Leaños-Miranda BE; Vilchis-Pérez M; Solórzano-Santos F
Ann Clin Microbiol Antimicrob; 2006 Oct; 5():25. PubMed ID: 17034644
[TBL] [Abstract][Full Text] [Related]
20. Imipenem therapy of experimental Staphylococcus aureus and Streptococcus faecalis endocarditis.
Scheld WM; Keeley JM
J Antimicrob Chemother; 1983 Dec; 12 Suppl D():65-78. PubMed ID: 6421794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]